Josephine Mansell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Josephine Mansell has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Adam Ioannou
National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, United Kingdom
2 shared publications - Aldostefano Porcari
Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste , Trieste
2 shared publications - Ana Martinez-Naharro
National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, UK
2 shared publications - Awais Sheikh
National Amyloidosis Centre, Division of Medicine, University College London, Royal Free Hospital, London, UK
2 shared publications - Helen J. Lachmann
National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom (A.I., J.M., A.S., L.V., Y.R., A.P., A.M.-N., M.U.R., H.L., P.N.H., A.W., J.D.G., M. Fontana)
2 shared publications - Julian David Gillmore
University College London, Royal Free Hospital
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 1 April 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 19 (4) , e018991
Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial Intelligence
BACKGROUND: Diagnosing cardiac amyloidosis (CA) on echocardiography can be challenging due to the imaging overlap between CA and more prevalent causes of a hypertrophic phenotype. This study sought to (1) evaluate the performance of artificial-intelligence (AI) derived measurements incorporated into the established multiparametric echocardiographic scoring system to detect CA; (2) develop and validate an AI-based deep-learning model for video-based detection of CA on echocardiography. METHODS: The study population comprised 5776 patients (CA, 2756; controls, 3020). The training data set included patients from the UK National Amyloidosis Center and Taiwan MacKay Memorial Hospital (CA, 2241; controls, 2130). External test data sets were obtained from the US Duke University Health System (CA, 334; left ventricular hypertrophy controls, 668) and Japan National Cerebral and Cardiovascular Center (CA, 181; left ventricular hypertrophy controls, 222). RESULTS: The multiparametric echocardiographic score computed using AI-derived measurements achieved an accuracy of 79.5% (sensitivity, 75.4%; specificity, 81.5%) in the United States cohort and 79.7% (sensitivity, 81.6%; specificity, 78.1%) in the Japan cohort. The deep-learning model demonstrated accuracies of 96.2% (sensitivity, 96.8%; specificity, 95.7%) and 95.8% (sensitivity, 97.3%; specificity, 94.3%) in the internal validation and internal test sets, respectively. External validation of the deep-learning model showed accuracies of 87.5% (sensitivity, 86.6%; specificity, 87.9%) in the United States and 88.4% (sensitivity, 92.3%; specificity, 85.3%) in the Japanese cohort. Subgroup analysis demonstrated that the deep-learning model showed robust discrimination of CA from other hypertrophic phenocopies: CA versus hypertension (area under the curve [AUC], 0.92 [95% CI, 0.91–0.94]), CA versus hypertrophic cardiomyopathy (AUC, 0.91 [95% CI, 0.87–0.94]), CA versus aortic stenosis (AUC, 0.93 [95% CI, 0.90–0.95]), CA versus chronic kidney disease (AUC, 0.93 [95% CI, 0.91–0.95]). The deep-learning model was able to classify a greater proportion of patients compared with the AI-derived multiparametric echocardiographic score and achieved superior diagnostic accuracy (AUC, 0.93 [95% CI, 0.91–0.95] versus AUC, 0.88 [95% CI, 0.85–0.90]; P <0.001). CONCLUSIONS: Both the multiparametric echocardiographic score computed from AI-derived measurements and the fully automated deep-learning model can accurately identify patients with CA in globally diverse cohorts, with the deep-learning model providing superior performance.
- 1 April 2026
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 19 (4) , e018991
Top Cited PapersOpen AccessDiagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial Intelligence
BACKGROUND: Diagnosing cardiac amyloidosis (CA) on echocardiography can be challenging due to the imaging overlap between CA and more prevalent causes of a hypertrophic phenotype. This study sought to (1) evaluate the performance of artificial-intelligence (AI) derived measurements incorporated into the established multiparametric echocardiographic scoring system to detect CA; (2) develop and validate an AI-based deep-learning model for video-based detection of CA on echocardiography. METHODS: The study population comprised 5776 patients (CA, 2756; controls, 3020). The training data set included patients from the UK National Amyloidosis Center and Taiwan MacKay Memorial Hospital (CA, 2241; controls, 2130). External test data sets were obtained from the US Duke University Health System (CA, 334; left ventricular hypertrophy controls, 668) and Japan National Cerebral and Cardiovascular Center (CA, 181; left ventricular hypertrophy controls, 222). RESULTS: The multiparametric echocardiographic score computed using AI-derived measurements achieved an accuracy of 79.5% (sensitivity, 75.4%; specificity, 81.5%) in the United States cohort and 79.7% (sensitivity, 81.6%; specificity, 78.1%) in the Japan cohort. The deep-learning model demonstrated accuracies of 96.2% (sensitivity, 96.8%; specificity, 95.7%) and 95.8% (sensitivity, 97.3%; specificity, 94.3%) in the internal validation and internal test sets, respectively. External validation of the deep-learning model showed accuracies of 87.5% (sensitivity, 86.6%; specificity, 87.9%) in the United States and 88.4% (sensitivity, 92.3%; specificity, 85.3%) in the Japanese cohort. Subgroup analysis demonstrated that the deep-learning model showed robust discrimination of CA from other hypertrophic phenocopies: CA versus hypertension (area under the curve [AUC], 0.92 [95% CI, 0.91–0.94]), CA versus hypertrophic cardiomyopathy (AUC, 0.91 [95% CI, 0.87–0.94]), CA versus aortic stenosis (AUC, 0.93 [95% CI, 0.90–0.95]), CA versus chronic kidney disease (AUC, 0.93 [95% CI, 0.91–0.95]). The deep-learning model was able to classify a greater proportion of patients compared with the AI-derived multiparametric echocardiographic score and achieved superior diagnostic accuracy (AUC, 0.93 [95% CI, 0.91–0.95] versus AUC, 0.88 [95% CI, 0.85–0.90]; P <0.001). CONCLUSIONS: Both the multiparametric echocardiographic score computed from AI-derived measurements and the fully automated deep-learning model can accurately identify patients with CA in globally diverse cohorts, with the deep-learning model providing superior performance.
- Open Access
- 3 February 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (5) , 364-366
Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study
- 3 February 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (5) , 364-366
Open AccessEfficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study
- 1 September 2018
- Published by BMJ in BMJ Case Reports
- Vol. 2018
Infective endocarditis due toAtopobium vaginae: a rare association between genital infection and endocarditis of the tricuspid valve
Atopobium vaginaeis an anaerobic gram-positive organism associated with genitourinary infections. Bacteraemia is rare, with only two cases reported in the literature. This case describes an 18-year-old type 1 diabetic, presenting with sepsis and haemoptysis, on a background of poor dental hygiene and recurrent hospital admissions. Blood cultures grewA. vaginaeand echocardiogram revealed a large tricuspid valve lesion. Despite medical therapy, symptoms of pulmonary emboli continued and she therefore underwent surgical resection of the lesion. Histopathological findings were of a vegetation; culture of the lesion was negative but 16S ribosomal PCR was positive, detecting 16S rRNA ofA. vaginae. The patient was treated with 4 weeks of vancomycin and made a good recovery. To our knowledge, this represents the first report of infective endocarditis due to this organism. We also provide a review of the literature, including comparing published drug susceptibility data with consensus breakpoints for antimicrobial agents.
- 1 September 2018
- Published by BMJ in BMJ Case Reports
- Vol. 2018
Infective endocarditis due toAtopobium vaginae: a rare association between genital infection and endocarditis of the tricuspid valve
Atopobium vaginaeis an anaerobic gram-positive organism associated with genitourinary infections. Bacteraemia is rare, with only two cases reported in the literature. This case describes an 18-year-old type 1 diabetic, presenting with sepsis and haemoptysis, on a background of poor dental hygiene and recurrent hospital admissions. Blood cultures grewA. vaginaeand echocardiogram revealed a large tricuspid valve lesion. Despite medical therapy, symptoms of pulmonary emboli continued and she therefore underwent surgical resection of the lesion. Histopathological findings were of a vegetation; culture of the lesion was negative but 16S ribosomal PCR was positive, detecting 16S rRNA ofA. vaginae. The patient was treated with 4 weeks of vancomycin and made a good recovery. To our knowledge, this represents the first report of infective endocarditis due to this organism. We also provide a review of the literature, including comparing published drug susceptibility data with consensus breakpoints for antimicrobial agents.